Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Y King

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Pharmaceutical Research|December 1, 1995
Dose-dependent pharmacokinetics of warfarin in healthy volunteersS Y King, M A Joslin, K Raudibaugh, et al.
Anesthesia and Analgesia|February 1, 1992
Lidocaine for the prevention of pain due to injection of propofolS Y King, F M Davis, J E Wells, et al.
Journal of Clinical Pharmacology|December 1, 1995
Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteersI H Benedek, A S Joshi, H J Pieniaszek, et al.
Journal of Chromatography. B, Biomedical Applications|October 3, 1994
Simultaneous quantification of an anti-inflammatory compound (DuP 697) and a potential metabolite (X6882) in human plasma and urine by high-performance liquid chromatographyA S Joshi, N Raghavan, R M Williams, et al.
Journal of Clinical Pharmacology|June 11, 1992
Effect of moricizine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteersI H Benedek, S Y King, R J Powell, et al.
Research Communications in Chemical Pathology and Pharmacology|March 11, 1992
Effects of multiple doses of moricizine hydrochloride on its pharmacokinetics and hepatic microsomal enzymes in ratsS Y King, R J Powel, Y N Wong, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Protein binding of brequinar in the plasma of healthy donors and cancer patients and analysis of the relationship between protein binding and pharmacokinetics in cancer patientsS Y King, A M Agra, H S Shen, et al.
Investigational New Drugs|September 18, 1998
Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignanciesH A Burris, E Raymond, A Awada, et al.
Journal of Clinical Pharmacology|March 20, 1998
Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipientsA S Joshi, S Y King, B A Zajac, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Pharmaceutical Research|December 1, 1995
Dose-dependent pharmacokinetics of warfarin in healthy volunteersS Y King, M A Joslin, K Raudibaugh, et al.
Anesthesia and Analgesia|February 1, 1992
Lidocaine for the prevention of pain due to injection of propofolS Y King, F M Davis, J E Wells, et al.
Journal of Clinical Pharmacology|December 1, 1995
Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteersI H Benedek, A S Joshi, H J Pieniaszek, et al.
Journal of Chromatography. B, Biomedical Applications|October 3, 1994
Simultaneous quantification of an anti-inflammatory compound (DuP 697) and a potential metabolite (X6882) in human plasma and urine by high-performance liquid chromatographyA S Joshi, N Raghavan, R M Williams, et al.
Journal of Clinical Pharmacology|June 11, 1992
Effect of moricizine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteersI H Benedek, S Y King, R J Powell, et al.
Research Communications in Chemical Pathology and Pharmacology|March 11, 1992
Effects of multiple doses of moricizine hydrochloride on its pharmacokinetics and hepatic microsomal enzymes in ratsS Y King, R J Powel, Y N Wong, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Protein binding of brequinar in the plasma of healthy donors and cancer patients and analysis of the relationship between protein binding and pharmacokinetics in cancer patientsS Y King, A M Agra, H S Shen, et al.
Investigational New Drugs|September 18, 1998
Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignanciesH A Burris, E Raymond, A Awada, et al.
Journal of Clinical Pharmacology|March 20, 1998
Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipientsA S Joshi, S Y King, B A Zajac, et al.
Pageof 2